LOW — Lowe's Companies, Inc.

The tape is unambiguously bearish. As of 2026-09-13 the stock sat 5.46% below its 20-day SMA, 6.94% below the 50-day and 16.48% below the 200-day, with RSI(14) at 33.84 - weak, but not yet the sub-30 capitulation that historically marks a tradeable bottom. The August 19, 2026 guidance cut (FY2026 sales to ~$92B from $92-94B, comps to flat, adjusted EPS to ~$12.25) confirmed what the housing data already implied: the DIY big-ticket customer is frozen, and Q2 comps of just +0.2% versus ~8% total sales growth revealed the growth is bought, not earned. The tell is the gap between the tape and the sell-side: 31 Buy / 19 Hold / 1 Sell with a $256.38 consensus target implies ~30% upside, meaning the market is discounting a longer housing freeze than analysts are, not a structurally broken business.

Revenue has inflected sharply higher but for the wrong reason. The last four reported quarters were $20.81B (Oct-25), $20.59B (Jan-26), $23.08B (May-26) and $25.96B (Jul-26), growing +3.2%, +10.9%, +10.3% and +8.3% YoY respectively - yet Q2 FY2026 comparable sales were only +0.2%, so essentially all of that top-line growth comes from the FBM and ADG acquisitions. Margins are the real story, and the compression is persistent rather than a blip: operating margin fell YoY in each of the last four quarters (Jul-26 13.67% vs 14.48%; May-26 11.07% vs 11.92%; Jan-26 8.30% vs 9.86%; Oct-25 11.92% vs 12.57%), and Q2 gross margin slipped to 33.05% from 33.81%. That flows through exactly where it should: diluted EPS was $4.27 in Q2 FY2026 versus $4.27 a year earlier, $2.90 vs $2.92 in Q1, $2.88 vs $2.99 in Q3 and $1.78 vs $2.00 in Q4 - roughly 8% more revenue and zero incremental EPS. Free cash flow remains the redeeming feature: $7.0B TTM through Jul-26 (versus $7.69B a year earlier), with $3.12B generated in the most recent quarter alone. Net: a decelerating organic business wearing a growing revenue coat.

Cheap versus its own history, not cheap in absolute terms. As of 2026-09-13 the stock trades at 16.6x TTM EPS of $11.88 and roughly 16.0x the $12.28 next-FY consensus EPS, against a 5-year average P/E of 19.97 - about a 17% discount. Price/sales of 1.22 also sits ~24% below the 5-year average of 1.60. The PEG of -5.63 is meaningless because it is distorted by flat-to-negative earnings growth. On the other side of the ledger, EV/EBITDA of 12.25x is not a bargain multiple for a retailer with flat comps, and the 2.37% dividend yield is only modestly above prevailing risk-free rates. The de-rating is a rational response to zero organic growth plus a balance sheet carrying $35.2B of long-term debt against -$7.4B of stockholders' equity.

This is a multiple-compression story, not an earnings-collapse story. EPS has been essentially flat for four straight quarters ($4.27, $2.90, $1.78, $2.88 in the most recent four) while the stock lost roughly a quarter of its value over twelve months - the market took the P/E from ~20x to ~16x without much change in the E. That distinction matters for downside: the remaining risk is mostly a further de-rating (14-15x on $12.28 = $172-184) rather than an earnings cliff, since the dividend at $1.25/quarter is covered more than twice by EPS. The upside case is equally clear: if comps stabilize at low-single-digit positive and margin compression stops, EPS grinds toward $13.00+ and 17x gets you $220+, with a genuine housing-turnover recovery making $240-250 reachable. As of 2026-09-13 the price is discounting the first scenario more than the second, which is why the $256 consensus target looks generous and the trough story is not yet paying investors to wait.

Bearish, and not oversold enough to matter yet. As of 2026-09-13, RSI(14) stood at 33.84 - below neutral but still above the 30 capitulation threshold - with the stock 5.46% under its 20-day SMA, 6.94% under the 50-day and 16.48% under the 200-day: a clean, persistent downtrend with no base forming. The $196.82 price is within $2 of the 52-week low of $195.06, and the 1-week (-3.73%) and 1-month (-8.87%) returns show selling accelerating rather than exhausting. Being 16.5% below the 200-day statistically sets up mean-reversion bounces, but without an RSI print under 30 or a positive comp headline there is no timing edge - the honest read is 'wait for a base,' not 'buy the dip.'

• Housing lock-in: elevated mortgage rates and home prices have frozen existing-home turnover, and big-ticket remodeling is tightly tied to moving and equity extraction - the single largest suppressor of DIY demand.
• Tariffs and supply-chain costs: management explicitly flagged tariff impacts and transportation cost headwinds requiring disciplined cost control to defend an 11.2-11.6% operating margin target.
• Consumer discretionary squeeze: persistent inflation is pushing lower- and middle-income households out of discretionary home improvement, while the Pro contractor segment remains the relative bright spot.
• Interest-rate path: a Fed easing cycle would be the most direct positive catalyst for housing turnover and therefore for big-ticket comps - the key macro swing factor for this stock.
• Sector rotation: consumer cyclical names with flat comps are out of favor, and LOW's low beta of 0.846 has not protected it from the de-rating.

• Q3 FY2026 earnings (expected mid-to-late November 2026): the key test of whether comparable sales hold flat or turn negative, plus any holiday and early-2027 housing commentary.
• FBM and ADG integration milestones: proof that the $96M of Q2 pre-tax deal costs convert into Pro-segment margin accretion rather than permanent gross-margin dilution (gross margin already fell to 33.05% from 33.81%).
• A housing-turnover inflection if mortgage rates fall - existing-home sales recovering would re-open the big-ticket remodel pipeline that drives DIY comps.
• Capital return: the $1.25 quarterly dividend (2.37% yield) and ongoing buybacks provide valuation support and shrink the share count even with flat net income.
• Multiple normalization: with the P/E at ~16.0x forward versus a 5-year average of 19.97, even modest EPS stabilization could trigger a re-rating toward the high teens.

• Comps rolling over from +0.2% to negative: the August 19, 2026 guidance cut already reset comps to flat, and further deterioration would break the entire 'trough, not decline' thesis.
• Relentless margin compression: operating margin has fallen YoY for four consecutive quarters and gross margin dropped ~76bp in Q2 FY2026 - the acquired Pro/distribution businesses carry structurally lower margins and may keep diluting company-level profitability.
• Balance sheet fragility: -$7.4B stockholders' equity, $35.2B of long-term debt and a quick ratio of just 0.265 leave little room for error, and the debt funded the acquisitions that are generating the revenue growth.
• Value-trap risk: the stock is 'cheap vs. its own history' (16.6x vs 19.97x average) but has gotten cheaper for five straight quarters - a discount multiple on flat earnings is not a catalyst.
• Tariff and cost inflation persisting into FY2027, forcing either margin sacrifice or price increases that further suppress unit demand.

Not a buy here, and not a short either - this is a good business at a trough-to-fair price with no visible catalyst. The quality is real: 20.4% ROIC, a -2.25% accruals ratio (cash earnings running ahead of reported profit), ~$7.0B of TTM free cash flow and a well-covered 2.37% dividend. But the operating reality is five consecutive quarters of ~80-95bp operating margin compression, organic comps of +0.2% dressed up by debt-funded acquisitions, and EPS that has gone nowhere for a year. At 16.0x forward earnings the stock is not expensive enough to be a value trap in the classic sense, but with the shares at a 52-week low, below all major moving averages and RSI at 33.84, there is no reason to be early. I would want either evidence that comps have turned positive or a washout toward the $180s before turning constructive.

I used a scenario-weighted forward P/E approach. Base case (60% weight): roughly 17x - a discount to the 5-year average of 19.97x to reflect flat comps and higher leverage - applied to next-FY consensus EPS of $12.28 gives $209. Bull case (25%): housing turnover recovers, comps turn low-single-digit positive, EPS reaches ~$13.50 at 18x = $243. Bear case (15%): comps turn negative and mix dilution continues, EPS slips to ~$11.20 at 15x = $168. Probability-weighted, that lands at ~$211, which cross-checks to roughly a 5.9% free cash flow yield on $7.0B TTM FCF - a reasonable ask for a mature retailer with modest growth and real leverage. That is well below the $256.38 analyst consensus because consensus appears to assume a housing recovery and multiple re-rating that the current comp trajectory does not yet support.